Seismic Therapeutic has dosed the first healthy participant cohort in the randomised Phase I trial of bifunctional antibody S ...

J&J has reported data from the Phase III ICONIC-LEAD trial’s subgroup analysis evaluating icotrokinra in treating plaque ...

AI tools are faster at drafting clinical trial documents, but human writers remain indispensable for logical reasoning.

Oculis has concluded subject enrolment for the Phase III clinical trials of OCS-01 eye drops for diabetic macular oedema.

Alzheon's Alzheimer's drug showed nominal benefit in a subgroup of patients who suffer with mild cognitive impairment.

At AAN 2025, three posters presented the sustained long-term efficacy and real-world impact of Lundbeck’s Vyepti for migraine ...

Three companies recently announced progression in their clinical research for next-generation Covid-19 vaccines: INOVIO, ...

Oral triptans are considered the industry gold standard acute treatments and there are currently seven approved, all with ...

One in three women will become pregnant after an MS diagnosis, therefore consideration of the maternal-infant dyad is needed.

April is dedicated to raising awareness of Parkinson’s disease to support individuals suffering from the condition and those ...

Annual Meeting Clinical Trials Plenary Session, Sanofi presented data on tolebrutinib in patients with non-relapsing ...

Agitated patients are often prescribed antipsychotic medications and sedatives off-label, but this can pose a risk to the ...